SecBot SecBot
8-K ·Filed Jul 23, 2026

ALUR

ALLURION TECHNOLOGIES, INC.
BEARISH
Impact 6/10
Horizondays Processed3mo ago SEC0001193125-26-314263
Actionable Insight ▼ Bearish

The immediate CEO resignation without a named successor is a red flag for a micro-cap OTC-traded company.

DirectionBearish
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
ALUR ▲ 0.00% at T+60d
SHORT call ✗ call lost 0.00% · α vs SPY +3.73% · entry $0.6711 → $0.6711
Entry = T+0 close
Jul 23, 2026
via day close
T+1d
0.00%
call 0.00% · α +0.02%
$0.6711
settled 3mo ago
T+5d
0.00%
call 0.00% · α +1.10%
$0.6711
settled 3mo ago
T+20d
0.00%
call 0.00% · α +3.63%
$0.6711
settled 2mo ago
T+60d
0.00%
call 0.00% · α +3.73%
$0.6711
settled 11d ago

Price Chart

Loading chart...

Executive Summary

CEO Shantanu K. Gaur resigned immediately on July 17, 2026, with no interim or permanent replacement named. COO Ojas Buch will oversee day-to-day operations without a title or compensation change. The sudden departure of the CEO with no succession plan is a significant leadership vacuum for a small-cap medical device company trading on the OTC market.

Key Facts

  • CEO Shantanu K. Gaur resigned effective immediately on July 17, 2026
  • No interim or permanent CEO has been appointed by the Board
  • COO Ojas Buch will oversee day-to-day operations without modified title or compensation
  • Resignation stated as not due to any disagreement with the Company or Board
  • Stock trades on OTC market (NONE exchange) with no analyst consensus price target available

Financial Impact

CEO departure with no replacement creates leadership uncertainty; no financial figures provided in filing

leadershipgovernance

Risk Factors

  • No CEO succession plan creates operational and strategic paralysis
  • Potential for further C-suite departures or loss of key talent
  • OTC listing and micro-cap status amplify downside from governance uncertainty

Market Snapshot

Exchange
OTC
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (ALUR) — Batch item 10001193125-26-314263
Document: 0001193125-26-314263-index-headers.html0001193125-26-314263
Document: 0001193125-26-314263-index.html0001193125-26-314263
Document: 0001193125-26-314263.txt0001193125-26-314263
8-K Filing (ALUR) — Batch item 50001193125-26-314263
Document: 0001193125-26-314263-index-headers.html0001193125-26-314263
Document: 0001193125-26-314263-index.html0001193125-26-314263
Document: 0001193125-26-314263.txt0001193125-26-314263
5 reports for ALUR
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ALUR — sortable, filterable
TypeNow
Oct 13, 2026
13d ago
25-NSE
BEARISH ★ 7/10
$0.6711 $0.6711· 0.00%▼ −1.15%$0.010000 (+98.51%)
Jul 23, 2026
13w ago
8-K
BEARISH ★ 6/10
$0.6711 $0.6711· 0.00%▲ +1.10%$0.010000 (+98.51%)
Jul 7, 2026
15w ago
8-K
NEUTRAL ★ 2/10
$0.6711 $0.6711· 0.00%▼ −0.55%$0.010000 (−98.51%)
Jun 30, 2026
16w ago
8-K
NEUTRAL ★ 2/10
$4.80 $5.32▲ +10.77%▲ +10.82%$0.010000 (−99.79%)
Feb 25, 2026
34w ago
8-K
NEUTRAL ★ 4/10
$1.23 $0.7590▼ −38.29%▼ −37.19%$0.010000 (−99.19%)
Showing 5 of 5

US Market Status

Market Closed — Opens in 4h 20m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 23, 2026